| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 464 |
| 1 | ETANERCEPT | 432 |
| 2 | UPADACITINIB | 339 |
| 3 | METHOTREXATE SODIUM | 265 |
| 4 | RISANKIZUMAB-RZAA | 258 |
| 5 | METHOTREXATE | 247 |
| 6 | PREDNISONE | 224 |
| 7 | ERGOCALCIFEROL | 201 |
| 8 | TOFACITINIB | 197 |
| 9 | ASPIRIN | 167 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 41 | 0.0119 |
| 1 | ELOSULFASE ALFA | 51 | 0.0092 |
| 2 | ERGOCALCIFEROL | 201 | 0.0068 |
| 3 | 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM | 1 | 0.0060 |
| 4 | GALSULFASE | 19 | 0.0049 |
| 5 | GOLIMUMAB | 61 | 0.0048 |
| 6 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 2 | 0.0041 |
| 7 | GAS RELIEF | 2 | 0.0041 |
| 8 | UPADACITINIB | 339 | 0.0040 |
| 9 | CEFADROXIL | 8 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 773 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 472 |
| 2 | Janus Kinase Inhibitor [EPC] | 350 |
| 3 | Corticosteroid [EPC] | 339 |
| 4 | Interleukin-23 Antagonist [EPC] | 315 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 245 |
| 6 | Benzodiazepine [EPC] | 210 |
| 7 | Provitamin D2 Compound [EPC] | 201 |
| 8 | Vitamin C [EPC] | 192 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 177 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 38 | 0.0552 |
| 1 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 18 | 0.0087 |
| 3 | Provitamin D2 Compound [EPC] | 201 | 0.0068 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 86 | 0.0064 |
| 5 | Adrenocorticotropic Hormone [EPC] | 4 | 0.0045 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 7 | Interleukin-23 Antagonist [EPC] | 315 | 0.0030 |
| 8 | Nonergot Dopamine Agonist [EPC] | 43 | 0.0028 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 10 | 0.0023 |